Interleukin-12 in Treating Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003149
Recruitment Status : Completed
First Posted : March 30, 2004
Last Update Posted : June 21, 2013
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : September 2006
Publications of Results:
Lacy MQ, Blood E, Kay N, et al.: Interleukin-12 treatment for plateau phase multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) phase II trial (E1A96). [Abstract] Blood 100 (11 pt 1): A-1549, 2002.